Clinical Trials Related to Non-metastatic Castration-Resistant Prostate Cancer

Related studies linked through entity extraction aliases.

An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

Status: NOT_YET_RECRUITING
Phase: N/A

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Status: RECRUITING
Phase: N/A

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Status: RECRUITING
Phase: PHASE4